Vext Science, Inc. (VEXT.CN)
CAD 0.13
(4.0%)
CAD 0.13
(4.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 54.57 Million USD | 12.3% |
| 2022 | 48.59 Million USD | 99.91% |
| 2021 | 24.31 Million USD | 27.0% |
| 2020 | 19.14 Million USD | 46.04% |
| 2019 | 13.1 Million USD | 103.73% |
| 2018 | 6.43 Million CAD | 26.99% |
| 2017 | 5.06 Million CAD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 56.55 Million USD | 4.04% |
| 2024 Q2 | 57.87 Million USD | 2.45% |
| 2023 FY | 54.57 Million USD | 12.3% |
| 2023 Q1 | 49.42 Million USD | 1.71% |
| 2023 Q2 | 48.64 Million USD | -1.58% |
| 2023 Q3 | 47.26 Million USD | -2.85% |
| 2023 Q4 | 54.57 Million USD | 15.48% |
| 2022 Q4 | 48.59 Million USD | 6.5% |
| 2022 FY | 48.59 Million USD | 99.91% |
| 2022 Q3 | 45.63 Million USD | 45.48% |
| 2022 Q2 | 31.36 Million USD | 2.39% |
| 2022 Q1 | 30.63 Million USD | 26.01% |
| 2021 Q1 | 19.96 Million USD | 4.29% |
| 2021 Q2 | 23.68 Million USD | 18.65% |
| 2021 FY | 24.31 Million USD | 27.0% |
| 2021 Q4 | 24.31 Million USD | 0.16% |
| 2021 Q3 | 24.27 Million USD | 2.48% |
| 2020 Q2 | 21.5 Million USD | 62.99% |
| 2020 FY | 19.14 Million USD | 46.04% |
| 2020 Q1 | 13.19 Million USD | 0.65% |
| 2020 Q4 | 19.14 Million USD | -9.67% |
| 2020 Q3 | 21.18 Million USD | -1.45% |
| 2019 FY | 13.1 Million USD | 103.73% |
| 2019 Q4 | 13.1 Million USD | 71.62% |
| 2019 Q3 | 7.63 Million USD | 3.86% |
| 2019 Q2 | 7.35 Million USD | 2.97% |
| 2019 Q1 | 7.14 Million CAD | 11.0% |
| 2018 Q4 | 6.43 Million USD | 0.0% |
| 2018 FY | 6.43 Million CAD | 26.99% |
| 2018 Q1 | - USD | 0.0% |
| 2017 FY | 5.06 Million CAD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Aion Therapeutic Inc. | 2.93 Million CAD | -1758.592% |
| Ayurcann Holdings Corp. | 14.31 Million CAD | -281.155% |
| Blueberries Medical Corp. | 470.72 Thousand CAD | -11494.405% |
| The BC Bud Corporation | 626 Thousand CAD | -8618.4% |
| BioNxt Solutions Inc. | 6.55 Million CAD | -733.217% |
| CordovaCann Corp. | 11.29 Million CAD | -383.375% |
| Christina Lake Cannabis Corp. | 8.5 Million CAD | -542.012% |
| Captor Capital Corp. | 28.76 Million CAD | -89.739% |
| City View Green Holdings Inc. | 3.73 Million CAD | -1362.039% |
| 1CM Inc. | 9.42 Million CAD | -479.153% |
| Global Hemp Group Inc. | 5.82 Million CAD | -836.93% |
| Greenway Greenhouse Cannabis Corporation | 21.17 Million CAD | -157.756% |
| IM Cannabis Corp. | 35.11 Million CAD | -55.434% |
| Lobe Sciences Ltd. | 2.45 Million CAD | -2118.943% |
| Maple Leaf Green World Inc. | 10.08 Million CAD | -441.393% |
| Mountain Valley MD Holdings Inc. | 258 Thousand CAD | -21054.082% |
| Nextleaf Solutions Ltd. | 4.4 Million CAD | -1139.454% |
| Ovation Science Inc. | 728.99 Thousand CAD | -7386.712% |
| Pharmadrug Inc. | 2.92 Million CAD | -1765.599% |
| Captiva Verde Wellness Corp. | 2.08 Million CAD | -2512.671% |
| RAMM Pharma Corp. | 2.83 Million CAD | -1824.786% |
| RIV Capital Inc. | 275.63 Million CAD | 80.2% |
| Revive Therapeutics Ltd. | 3.4 Million CAD | -1503.366% |
| Red White & Bloom Brands Inc. | 364.63 Million CAD | 85.032% |
| SLANG Worldwide Inc. | 37.58 Million CAD | -45.22% |
| 1933 Industries Inc. | 23.28 Million CAD | -134.411% |
| Red Light Holland Corp. | 3.82 Million CAD | -1328.111% |
| Top Strike Resources Corp. | 20.99 Million CAD | -159.967% |
| Xebra Brands Ltd. | 789.95 Thousand CAD | -6808.942% |
| Adastra Holdings Ltd. | 17.65 Million CAD | -209.088% |